Non-small cell lung cancer staging: proposed revisions to the TNM system

由 Schneider, Bryan J.
出版 2008

Non-Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers

由 Scheff, Ronald J., Schneider, Bryan J.
出版 2013

Non–Small-Cell Lung Cancer: Treatment of Late Stage Disease: Chemotherapeutics and New Frontiers

由 Scheff, Ronald J., Schneider, Bryan J.
發表在 Semin Intervent Radiol (2013)

Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis

由 Reddy, Haritha G., Schneider, Bryan J., Tai, Andrew W.
發表在 Clin Transl Gastroenterol (2018)

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis

由 Reddy, Haritha G., Schneider, Bryan J., Tai, Andrew W.
發表在 Clin Transl Gastroenterol (2018)

Chemotherapy and Radiation versus Chemotherapy Alone for Elderly Patients with N3 Stage IIIB NSCLC

由 Qin, Angel, Lusk, Elizabeth, Daignault-Newton, Stephanie, Schneider, Bryan J.
發表在 Clin Lung Cancer (2019)

Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent

由 Saxena, Ashish, Schneider, Bryan J., Christos, Paul J., Audibert, Lauren, Cagney, Jennifer M., Scheff, Ronald J.
發表在 Med Oncol (2016)

PHASE II STUDY OF CELECOXIB AND DOCETAXEL IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH PROGRESSION AFTER PLATINUM-BASED THERAPY

由 Schneider, Bryan J., Kalemkerian, Gregory P., Kraut, Michael J., Wozniak, Antoinette J., Worden, Francis P., Smith, Daryn W., Chen, Wei, Gadgeel, Shirish M.
出版 2008

Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non—Small-cell Lung Cancer

由 Schneider, Bryan J., Kalemkerian, Gregory P., Gadgeel, Shirish M., Valdivieso, Manuel, Hackstock, Deborah M., Chen, Wei, Heilbrun, Lance K., Ruckdeschel, John C., Wozniak, Antoinette J.
發表在 Clin Lung Cancer (2016)

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer

由 Schneider, Bryan J., Lee, Julia Shin-Jung, Hayman, James A., Chang, Andrew C., Orringer, Mark B., Pickens, Allan, Pan, Charlie C., Merajver, Sofia D., Urba, Susan G.
發表在 Invest New Drugs (2012)

Phase I study of epigenetic priming with azacitidine prior to standard neoadjuvant chemotherapy for patients with resectable gastric and esophageal adenocarcinoma: Evidence of tumo...

由 Schneider, Bryan J., Shah, Manish A., Klute, Kelsey, Ocean, Allyson, Popa, Elizabeta, Altorki, Nasser, Lieberman, Michael, Schreiner, Andrew, Yantiss, Rhonda, Christos, Paul J., Palmer, Romae, You, Daoqi, Viale, Agnes, Kermani, Pouneh, Scandura, Joseph M.
發表在 Clin Cancer Res (2016)

Chemotherapy Use, Performance Status, and Quality of Life at the End of Life

由 Prigerson, Holly G., Bao, Yuhua, Shah, Manish A., Paulk, M. Elizabeth, LeBlanc, Thomas W., Schneider, Bryan J., Garrido, Melissa M., Reid, M. Carrington, Berlin, David A., Adelson, Kerin B., Neugut, Alfred I., Maciejewski, Paul K.
發表在 JAMA Oncol (2015)

High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients

由 Zeinali, Mina, Lee, Maggie, Nadhan, Arthi, Mathur, Anvya, Hedman, Casey, Lin, Eric, Harouaka, Ramdane, Wicha, Max S., Zhao, Lili, Palanisamy, Nallasivam, Hafner, Mathias, Reddy, Rishindra, Kalemkerian, Gregory P., Schneider, Bryan J., Hassan, Khaled A., Ramnath, Nithya, Nagrath, Sunitha
發表在 Cancers (Basel) (2020)

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Patients With...

由 Edelman, Martin J., Tan, Ming T., Fidler, Mary J., Sanborn, Rachel E., Otterson, Greg, Sequist, Lecia V., Evans, Tracey L., Schneider, Bryan J., Keresztes, Roger, Rogers, John S., de Mayolo, Jorge Antunez, Feliciano, Josephine, Yang, Yang, Medeiros, Michelle, Zaknoen, Sara L.
發表在 J Clin Oncol (2015)

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

由 Brahmer, Julie R., Lacchetti, Christina, Schneider, Bryan J., Atkins, Michael B., Brassil, Kelly J., Caterino, Jeffrey M., Chau, Ian, Ernstoff, Marc S., Gardner, Jennifer M., Ginex, Pamela, Hallmeyer, Sigrun, Chakrabarty, Jennifer Holter, Leighl, Natasha B., Mammen, Jennifer S., McDermott, David F., Naing, Aung, Nastoupil, Loretta J., Phillips, Tanyanika, Porter, Laura D., Puzanov, Igor, Reichner, Cristina A., Santomasso, Bianca D., Seigel, Carole, Spira, Alexander, Suarez-Almazor, Maria E., Wang, Yinghong, Weber, Jeffrey S., Wolchok, Jedd D., Thompson, John A.
發表在 J Clin Oncol (2018)